Skip to content
Search

Latest Stories

Thornton&Ross offers free skincare to NHS staff

Huddersfield based Thornton & Ross is offering free samples from two of its skincare ranges to NHS frontline staff.

In a bid to support healthcare workers, STADA Group’s arm is donating free samples from Cetraben and Zeroderma emollient ranges to alleviate dry skin issues as NHS staff work around the clock as the deadly Covid-19 pandemic spreads across the UK.


NHS workers have reported that Covid-19 preventive measures such as, more frequent hand washing and use of hand sanitisers, are drying out their skin, while prolonged use of facemasks can result in skin irritation.

Emollients help the skin to retain moisture in the outer layers and replace lost oils, whilst protecting damaged or inflamed skin.

The samples are in 30 gram (g) and 50g-sized tubes and pumps, which fit neatly into a pocket, eliminate the cross-infection risks associated with full-size containers.

Each NHS member of staff will receive six samples of either Cetraben or Zeroderma, the company said in a statement.

Janet Maclean, Director of Marketing for the prescription division, commented: “When we were made aware that nurses and other frontline staff were suffering with skin problems as a result of increased hand washing and use of sanitisers, we wanted to help.

“Both Cetraben and Zeroderma are ideal for relieving irritation caused by these factors, and also from prolonged use of face masks while treating patients. As the UK’s leading prescription emollient company, it goes without saying that we are only too happy to support our NHS colleagues at this critical time.”

Cetraben is the first eczema-prone skincare range to be approved by the British Skin Foundation.

Zeroderma is one of the most widely available skincare ranges available on prescription in the UK and offers cost-effective treatments for a wide variety of skin types and conditions.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less